Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
 

 

TTD Drug ID: DAP000290

Drug Information
NameCalcidiol    
SynonymsVDY; MolPort-003-927-271; HMS1791G13; 3-{2-[1-(5-HYDROXY-1,5-DIMETHYL-HEXYL)-7A-METHYL-OCTAHYDRO-INDEN-4-YLIDENE]-ETHYLIDENE}-4-METHYLENE-CYCLOHEXANOL; 19356-17-3; Calderol; DB00146; H4014_SIGMA; HMS1361G13; Delakmin; Calcifediol; ZINC04474414; (1R,3Z)-3-[(2E)-2-[(1R,7aR)-1-[(2R)-6-hydroxy-6-methylheptan-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexan-1-ol; (5Z,7E)-9,10-Seco-5,7,10(19)-cholestatrien-3beta,25-diol; 9,10-Secocholesta-5,7,10(19)-triene-1,25-diol, (3.beta,.5Z,7E)-; BML2-E02; 5,6-trans-25-Hydroxycholescalciferol; B91135EC-8937-4D8B-A533-CCD82F33C1B0; 25-Hydroxycholecalciferol (Calcifediol); Calcifidiol; Cholecalciferol, 25-hydroxy-; Calcifediol anhydrous; 25-(OH)Vitamin D3; 9,10-Secocholesta-5,7,10(19)-triene-3beta,25-diol; 25631-40-7; S1469_Selleck; 5,6-cis-25-Hydroxyvitamin D3; EINECS 242-990-9; Calcifediolum; 25-Hydroxycholescalciferol; (1S,3Z)-3-[(2E)-2-[(1R,3aS,7aR)-1-[(2R)-6-hydroxy-6-methylheptan-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexan-1-ol; Calcifediolum [INN-Latin]; 17938_SIGMA; 9,10-Secocholesta-5,7,10(19)-triene-3,25-diol, (3beta,5Z,7E)-; IDI1_033881; Calcidiol; 25-Hydroxycholecalciferol; 25-hydroxyvitamin D3; 25-Hydroxyvitamin D3 monohydrate; U-32070E; NCGC00161326-04; 25-Hydroxyvitamin D; CID5283731; CID6433735; 5,6-trans-9,10-Seco-5,7,10(19)-cholestatrien-3beta,25-diol; CHEMBL1040; AC1O5GOQ; (3S,5Z,7E)-9,10-secocholesta-5,7,10-triene-3,25-diol; (3beta,5Z,7E)-9,10-secocholesta-5,7,10(19)-triene-3,25-diol; C01561; LMST03020246; CHEMBL1222; AC1NR2WF; UNII-T0WXW8F54E; 17938_FLUKA; CHEBI:17933; HMS2089L21; Spectrum5_001931; (3S,5Z,7E)-9,10-secocholesta-5,7,10(19)-triene-3,25-diol; HMS1989G13; Ro 8-8892; (5Z,7E)-(3S)-9,10-secocholesta-5,7,10(19)-triene-3,25-diol; NCGC00161326-01; 25(OH)D3; BSPBio_001411    
CompanyUnited Research Laboratories    
IndicationVitamin D deficiencyApproved    [1]
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
   
Therapeutic ClassVitamins    
CAS NumberCAS 19356-17-3
FormularC27H44O2    
PubChem Compound IDCID 6433735.    
PubChem Substance IDSID 171856.    
ChEBI17933;    
SuperDrug ATC IDA11CC06;    
SuperDrug CAS ID019356173;    
TargetVitamin D receptorAntagonist[2][3]
Ref 1Drug Information of Carbetocin from NEXTBIO. To Reference
Ref 2Vitamin D in health and disease. Clin J Am Soc Nephrol. 2008 Sep;3(5):1535-41. Epub 2008 Jun 4. To Reference
Ref 3Overview of general physiologic features and functions of vitamin D. Am J Clin Nutr. 2004 Dec;80(6 Suppl):1689S-96S. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

 
   
           
 
Computer-aided Drug Design
About BIDD | Databases | Software | Teaching | Research |  Links

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543